Allergic Rhinitis and Asthma
Allergic rhinitis and asthma are conditions caused by allergic reactions, often triggered by allergens like house dust mites. Symptoms can include sneezing, nasal congestion, itchy eyes, and difficulty breathing.
Allergy Relief: Sublingual Immunotherapy for House Dust Mite Allergies
We are studying a new treatment for individuals aged 12-65 with rhinitis or asthma caused by house dust mites. The goal is to see if this therapy can improve allergy symptoms compared to a placebo.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 12 and 65 years old?
- Do you have a history of moderate to severe allergic rhinitis (nasal allergy) for at least 1 year?
- Are you currently pregnant or breastfeeding?
- Do you have asthma that is well-controlled with medication?
- Are you taking any medications for other health issues, like blood pressure or heart problems?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
MM09
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
CCAB Centro Clinico Academico Braga Associacao
Allergology
Gualtar, Portugal
Unidade Local De Saude De Santo Antonio E.P.E.
Allergology
Massarelos, Portugal
Hospital Distrital De Santarem E.P.E.
Allergology
Santarém, Portugal
Sponsor: Inmunotek S.L.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.